Sangstat Medical Corporation

Fremont, CA 94555

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $99.1K
First Award Date 03/03/98
Most Recent Award Date 09/15/00

Key Personnel

Last Name Name Awards Contact
Cho Moo J Cho 1
Buelow Roland Buelow 1

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Budget: 09/15/00 - 09/14/01

RDP58, a novel TNF inhibitor developed by SangStat Medical Corporation, has been shown to successfully suppress clinical and histological disease in mouse and monkey colitis models following oral administration. Gastrointestinal complications, similar to chronic colitis, are commonly seen in HIV-infected patients that lead to nutrient malabsorpt...

Phase 1 STTR

Agency: Department of Health & Human Services
Budget: 03/03/98 - 02/28/99
PI: Moo J Cho

DESCRIPTION: Human and Old World primates naturally produce a large amount of antibodies which recognize an epitope Gal alpha 1-->3Gal. The present proposal is to test if the antibodies can be directed to folate receptor-expressing cancerous cells by means of a small MW targeting ligand that consists of...